Genetic discrimination (GD) involves an individual or a group being negatively treated, unfairly profiled, or harmed, relative to the rest of the population, on the basis of actual or presumed genetic characteristics. For decades, GD has been a global phenomenon that impacts fundamental human rights such as dignity, justice and equity. GD occurs not only in healthcare and insurance but also in employment, sports, education, immigration, housing, and forensic profiling. To address the growing burden of GD, states worldwide have adopted different legal frameworks. Despite these initiatives, concerns about GD persist and countries struggle on how to best approach this evolving issue.
Formed by the Regulatory & Ethics Work Stream (REWS), the Genetic Discrimination group — in collaboration with the Genetic Discrimination Observatory — aims to provide resources to support the development of policies to protect individuals or groups from genetic discrimination. In January 2022, the group produced a document that explores the current landscape of genetic discrimination, what we know, current challenges, and the implications of genetic discrimination on data sharing projects. The group has also finalized a GD Position Statement, based on its previous work, including a proposed consensus definition of GD and a Delphi study that identified the key elements of an optimal genetic non-discrimination policy. The Position Statement was approved by the GA4GH Product Steering Committee for approval in January 2026.
Benefits
- Explores genetic discrimination and how it impacts people and communities
- Provides resources to help institutions develop policies to prevent genetic discrimination
- Provides accessible information to researchers about genetic discrimination to address inquiries from participants
- Promotes international harmonisation of legal and ethical norms addressing genetic discrimination
- Enables better communication between genomic researchers and patients of diverse nationalities and cultures
Target users
Researchers, clinicians, clinical laboratories, data custodians, ethics review committees, data protection authorities, research participants & patient communities, and research institutes
Publications
| Title | Author(s) | Year |
|---|---|---|
| The Key Features of a Genetic Nondiscrimination Policy: A Delphi Consensus Statement | 2024 |
Documents
| Date | Title |
|---|---|
| 2 March 2026 | Definition of Genetic Discrimination |
| 27 February 2026 | Genetic Discrimination Toolkit: Position Statement on Genetic Discrimination |
| 7 May 2025 | Genetic Discrimination Toolkit Meeting Minutes (May 2025) |
| 16 May 2024 | Genetic Discrimination Toolkit Meeting Minutes (May 2024) |
| 14 September 2023 | Code of Ethics and Community Conduct (CECC) |
| 30 August 2022 | Meeting agenda: REWS — Genetic Discrimination |
| 19 April 2022 | Working document: Genetic Discrimination paper questions |
| 23 February 2022 | Meeting agenda: REWS — Genetic Discrimination (23 Feb 2022) |
| 2 December 2021 | Genetic Discrimination: Implications for Data Sharing Projects (GeDI) (v1.0) |
| 28 May 2021 | Meeting agenda: REWS — Genetic Discrimination (28 May 2021) |
| 8 April 2021 | Meeting agenda: REWS — Genetic Discrimination (8 Apr 2021) |
Contributors
Don't see your name..?
Get in touch- Beatrice KaiserMcGill University / Université McGill, Montréal, Canada, Centre of Genomics and Policy, Montreal
- Diya UberoiMcGill University / Université McGill, Montréal, Canada, Centre of Genomics and Policy, Montreal